|
Parkinson's disease
Citations 1-10 of 293 total displayed.
|
Most recent content
(1 Jun 2006):
|
- Short reports
Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study
- M Brandt-Christensen, K Kvist, F M Nilsson, P K Andersen, and L V Kessing
J Neurol Neurosurg Psychiatry 2006; 77: 781-783.
[Abstract]
[Full text]
|
Past content
(since Jul 1999):
|
- Papers
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease
- P Sockeel, K Dujardin, D Devos, C Denève, A Destée, and L Defebvre
J Neurol Neurosurg Psychiatry 2006; 77: 579-584.
[Abstract]
[Full text]
[ Web-only appendix ]
- Papers
Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies
- D J Burn, E N Rowan, L M Allan, S Molloy, J T O’Brien, and I G McKeith
J Neurol Neurosurg Psychiatry 2006; 77: 585-589.
[Abstract]
[Full text]
- Short reports
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson’s disease cohort
- C H Williams-Gray, A Goris, T Foltynie, J Brown, M Maranian, A Walton, D A S Compston, S J Sawcer, and R A Barker
J Neurol Neurosurg Psychiatry 2006; 77: 665-667.
[Abstract]
[Full text]
- Letters
Parkinsonism in type 1 Gaucher’s disease
- M Spitz, R Rozenberg, P A A Silveira, and E R Barbosa
J Neurol Neurosurg Psychiatry 2006; 77: 709-710.
[Extract]
[Full text]
- Papers
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease
- V Fraix, J-L Houeto, C Lagrange, C Le Pen, P Krystkowiak, D Guehl, C Ardouin, M-L Welter, F Maurel, L Defebvre, A Rougier, A-L Benabid, V Mesnage, M Ligier, S Blond, P Burbaud, B Bioulac, A Destée, P Cornu, P Pollak on behalf of the SPARK Study Group
J Neurol Neurosurg Psychiatry 2006; 77: 443-449.
[Abstract]
[Full text]
- Papers
Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson’s disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus
- D De Gaspari, C Siri, A Landi, R Cilia, A Bonetti, F Natuzzi, L Morgante, C B Mariani, E Sganzerla, G Pezzoli, and A Antonini
J Neurol Neurosurg Psychiatry 2006; 77: 450-453.
[Abstract]
[Full text]
- Papers
Visuospatial functions in atypical parkinsonian syndromes
- T H Bak, D Caine, V C Hearn, and J R Hodges
J Neurol Neurosurg Psychiatry 2006; 77: 454-456.
[Abstract]
[Full text]
- Papers
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
- D R Williams, H C Watt, and A J Lees
J Neurol Neurosurg Psychiatry 2006; 77: 468-473.
[Abstract]
[Full text]
- Letters
Cognitive changes in Parkinson’s disease during subthalamic stimulation: a clinicopathologic study
- F Valldeoriola, E Tolosa, M Alegret, M J Rey, O Morsi, M Pilleri, and J Rumià
J Neurol Neurosurg Psychiatry 2006; 77: 565-566.
[Extract]
[Full text]
|
|
